Lineage Cell Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Lineage Cell Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
  • Lineage Cell Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.27M, a 0.86% decline year-over-year.
  • Lineage Cell Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $4.64M, a 8.23% increase from 2022.
  • Lineage Cell Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.29M.
  • Lineage Cell Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2018 was $298M.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.64M +$353K +8.23% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $4.29M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2018 $298M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2016 $7.95M -$3.1M -28% Jan 1, 2016 Dec 31, 2016 10-K 2017-03-16
2015 $11.1M +$6.6M +148% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-16
2014 $4.46M +$1.41M +46.3% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 $3.05M +$1.2M +65.1% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $1.84M +$41.5K +2.31% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-11
2011 $1.8M +$709K +64.8% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-17
2010 $1.09M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.